Siemens Denied Patent Rehearing In Enzo DNA Spat
Siemens Healthcare Diagnostics has lost its bid for a rehearing of the U.S. Board of Patent Appeals and Interferences' decision to award Enzo Biochem Inc. priority to an invention for nucleic...To view the full article, register now.
Already a subscriber? Click here to view full article